Semi-Annual Balance Sheet

Delta-Fly Pharma, Inc. - Filing #7583108

Concept As at
2022-09-30
As at
2022-03-31
Semi-annual balance sheet
Balance sheet
Assets
Current assets
Cash and deposits
667,706,000 JPY
1,268,492,000 JPY
Other
23,160,000 JPY
12,315,000 JPY
Current assets
690,867,000 JPY
1,280,807,000 JPY
Non-current assets
Property, plant and equipment
Property, plant and equipment
39,434,000 JPY
39,933,000 JPY
Investments and other assets
Investments and other assets
3,273,000 JPY
3,611,000 JPY
Non-current assets
42,708,000 JPY
43,545,000 JPY
Assets
733,575,000 JPY
1,324,352,000 JPY
Liabilities
Current liabilities
Income taxes payable
18,306,000 JPY
19,886,000 JPY
Other
2,068,000 JPY
1,961,000 JPY
Current liabilities
123,036,000 JPY
91,190,000 JPY
Accounts payable - other
102,662,000 JPY
69,343,000 JPY
Liabilities
123,036,000 JPY
91,190,000 JPY
Other liabilities
Other liabilities
Net assets
Shareholders' equity
Share capital
3,352,327,000 JPY
3,352,327,000 JPY
Capital surplus
Capital surplus
3,332,327,000 JPY
3,332,327,000 JPY
Retained earnings
Retained earnings
-6,074,529,000 JPY
-5,451,943,000 JPY
Treasury shares
-337,000 JPY
-300,000 JPY
Shareholders' equity
609,788,000 JPY
1,232,411,000 JPY
Net assets
610,538,000 JPY
1,233,161,000 JPY
Share acquisition rights
750,000 JPY
750,000 JPY
Liabilities and net assets
733,575,000 JPY
1,324,352,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.